0,916  0,003  Antipsoriatic
0,884  0,003  GST A substrate
0,867  0,004  Bone diseases treatment
0,846  0,004  Antiosteoporotic
0,762  0,009  Antidiabetic
0,762  0,009  Cyclophilin D inhibitor
0,760  0,016  Caspase 9 stimulant
0,741  0,005  Skin irritative effect
0,716  0,005  NOS3 expression inhibitor
0,688  0,005  Lipoprotein disorders treatment
0,680  0,004  Anesthetic general
0,670  0,009  Analeptic
0,667  0,007  Immunomodulator
0,667  0,007  Eye irritation, high
0,659  0,002  Cyclin B3 inhibitor
0,650  0,008  Cardiovascular analeptic
0,647  0,010  Atherosclerosis treatment
0,649  0,013  Aldehyde oxidase inhibitor
0,633  0,005  Hypolipemic
0,640  0,019  TNF expression inhibitor
0,626  0,015  Cholesterol antagonist
0,601  0,004  Antidiabetic (type 1)
0,590  0,006  FMO1 substrate
0,588  0,014  CTGF expression inhibitor
0,593  0,023  Antineoplastic (solid tumors)
0,572  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,571  0,003  GST M1-1 substrate
0,569  0,003  GST P1-1 substrate
0,586  0,025  Teratogen
0,565  0,004  Antiparkinsonian, rigidity relieving
0,575  0,017  5 Hydroxytryptamine release stimulant
0,575  0,024  Embryotoxic
0,600  0,054  Antiinflammatory
0,561  0,017  Antipruritic, allergic
0,552  0,012  Metabolic disease treatment
0,563  0,026  Antiobesity
0,559  0,022  Respiratory analeptic
0,551  0,020  Immunosuppressant
0,548  0,021  Antihypercholesterolemic
0,545  0,029  Rheumatoid arthritis treatment
0,533  0,018  GABA C receptor rho-3 antagonist
0,519  0,015  Antidiabetic (type 2)
0,502  0,004  Tyrosine 3 hydroxylase inhibitor
0,501  0,005  Insulin secretagoues
0,503  0,010  Sedative
0,496  0,005  Antiacne
0,516  0,028  5 Hydroxytryptamine release inhibitor
0,525  0,037  CYP3A4 substrate
0,508  0,031  Prostate cancer treatment
0,480  0,005  Endometrios treatment
0,500  0,028  Vasodilator, peripheral
0,478  0,012  Peroxidase inhibitor
0,445  0,004  Alcohol oxidase inhibitor
0,445  0,004  CNS active muscle relaxant
0,478  0,037  Histamine release inhibitor
0,448  0,008  5 Hydroxytryptamine uptake stimulant
0,454  0,022  Proliferative diseases treatment
0,433  0,004  GABA C receptor agonist
0,437  0,011  Abortion inducer
0,466  0,039  Toll-Like receptor agonist
0,435  0,009  Antieczematic atopic
0,439  0,013  Calcium channel activator
0,444  0,020  Cardiodepressant
0,492  0,077  Apoptosis agonist
0,444  0,032  Multiple sclerosis treatment
0,415  0,004  Ferrochelatase inhibitor
0,434  0,023  UGT2B4 substrate
0,447  0,044  Toll-Like receptor 7 agonist
0,435  0,032  Cardioprotectant
0,411  0,011  Anesthetic
0,435  0,043  Ulceration
0,422  0,031  Chemoprotective
0,419  0,031  UGT1A9 substrate
0,403  0,017  FMO3 substrate
0,411  0,025  Chronic obstructive pulmonary disease treatment
0,391  0,007  Antiparkinsonian, tremor relieving
0,414  0,031  Cytostatic
0,387  0,006  Psychosexual dysfunction treatment
0,409  0,029  Mutagenic
0,414  0,036  AR expression inhibitor
0,449  0,072  Antiarthritic
0,392  0,020  Interleukin agonist
0,405  0,034  Vasodilator, coronary
0,377  0,007  Neurotrophic factor enhancer
0,410  0,042  Caspase 3 stimulant
0,390  0,023  Antihypertriglyceridemic
0,389  0,027  Urologic disorders treatment
0,391  0,030  Radiosensitizer
0,383  0,024  DNA synthesis inhibitor
0,369  0,010  Acaricide
0,373  0,023  Flavin-containing monooxygenase substrate
0,427  0,078  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,354  0,005  Succinate dehydrogenase inhibitor
0,361  0,013  Skeletal muscle relaxant
0,351  0,004  Triose-phosphate isomerase inhibitor
0,377  0,031  Antineoplastic (lymphoma)
0,376  0,032  Hypoglycemic
0,347  0,004  Cyclin B1 inhibitor
0,356  0,014  Hair growth stimulant
0,344  0,003  Cyclin B2 inhibitor
0,342  0,001  Parathyroid hormone antagonist
0,358  0,017  Antiseptic
0,354  0,014  Interferon gamma antagonist
0,390  0,052  Antithrombotic
0,351  0,014  Pneumotoxic
0,352  0,015  Antipruritic, non-allergic
0,337  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,380  0,047  Antihypertensive
0,363  0,032  Myocardial infarction treatment
0,365  0,036  Carcinogenic
0,341  0,013  Gastrin inhibitor
0,330  0,002  Hypercalcemia treatment
0,346  0,020  Non-steroidal antiinflammatory agent
0,345  0,023  Muscle relaxant
0,381  0,069  CYP2C9 substrate
0,330  0,018  Melanin inhibitor
0,320  0,009  Antihyperlipoproteinemic
0,367  0,059  Immunostimulant
0,309  0,004  Argininosuccinate synthase inhibitor
0,338  0,034  Psychostimulant
0,338  0,037  Vascular (periferal) disease treatment
0,404  0,104  Autoimmune disorders treatment
0,331  0,034  Antiulcerative
0,308  0,011  Cholesterol synthesis inhibitor
0,320  0,024  Antimutagenic
0,342  0,045  NOS2 expression inhibitor
0,336  0,040  Superoxide dismutase inhibitor
0,306  0,010  UGT2B9 substrate
0,296  0,003  GST T1-1 substrate
0,302  0,013  Glutathione S-transferase substrate
0,321  0,034  Antineoplastic (bladder cancer)
0,298  0,010  Carcinogenic, group 1
0,347  0,061  Hepatic disorders treatment
0,314  0,029  RNA-directed DNA polymerase inhibitor
0,288  0,004  Cyclin B inhibitor
0,287  0,005  GABA C receptor antagonist
0,306  0,025  UGT2B7 substrate
0,284  0,004  MAP kinase kinase 5 inhibitor
0,284  0,005  Carbamoyl phosphate synthetase inhibitor
0,327  0,049  Sensitization
0,283  0,006  Phosphofructokinase-1 inhibitor
0,285  0,009  Excitatory amino acid transporter EAAC1 inhibitor
0,330  0,054  Sodium/bile acid cotransporter inhibitor
0,313  0,037  Anticonvulsant
0,273  0,003  Antidote, mercury
0,280  0,011  SULT1A3 substrate
0,273  0,008  Contraceptive male
0,304  0,042  Antiparasitic
0,315  0,053  Antihypoxic
0,262  0,003  Fumarate hydratase inhibitor
0,265  0,007  Glutamate dehydrogenase inhibitor
0,288  0,029  VCAM1 expression inhibitor
0,290  0,034  Antihelmintic
0,262  0,007  Porphobilinogen synthase inhibitor
0,261  0,009  Adenylate kinase inhibitor
0,275  0,024  Sepsis treatment
0,322  0,071  Antifungal
0,315  0,065  Antiepileptic
0,280  0,030  Urinary incontinence treatment
0,295  0,046  UGT1A6 substrate
0,253  0,004  Antineoplastic alkaloid
0,270  0,022  Phospholipase C inhibitor
0,292  0,043  Chemopreventive
0,249  0,001  Vitamin D receptor antagonist
0,261  0,013  Uterine stimulant
0,256  0,012  UGT2B10 substrate
0,334  0,093  Antineoplastic (myeloid leukemia)
0,250  0,009  Antispirochetal
0,332  0,092  Antiasthmatic
0,304  0,065  CYP2C19 substrate
0,257  0,019  Toxic, respiratory center
0,246  0,008  Raynaud's phenomenon treatment
0,248  0,010  SULT1A1 substrate
0,275  0,037  Antiviral (Influenza)
0,266  0,028  Contraceptive
0,244  0,009  Antirickettsial
0,320  0,086  Transcription factor NF kappa B inhibitor
0,259  0,026  Carcinogenic, group 3
0,240  0,009  Catalase inhibitor
0,298  0,068  Radioprotector
0,239  0,010  Androgen antagonist
0,253  0,024  Antiviral (Influenza A)
0,255  0,029  UGT1A3 substrate
0,245  0,021  Anesthetic local
0,231  0,007  Creatine kinase inhibitor
0,243  0,019  Antifungal enhancer
0,261  0,038  UGT1A4 substrate
0,226  0,004  Hyperparathyroidism treatment
0,233  0,010  Arachidonic acid antagonist
0,313  0,091  Inflammatory Bowel disease treatment
0,224  0,005  Peroxisome proliferator-activated receptor gamma agonist
0,251  0,033  Lipocortins synthesis antagonist
0,222  0,004  Neuraminidase (influenza) inhibitor
0,264  0,048  Nitric oxide antagonist
0,263  0,047  Antihypotensive
0,227  0,012  Choleretic
0,230  0,015  UDP-glucose 4-epimerase inhibitor
0,226  0,011  CF transmembrane conductance regulator agonist
0,215  0,004  Glycine receptor agonist
0,267  0,058  Cytotoxic
0,239  0,031  Amylase inhibitor
0,216  0,008  Antiviral (Influenza B)
0,210  0,002  Anesthetic inhalation
0,292  0,086  CYP2D6 substrate
0,223  0,017  Carcinogenic, group 2B
0,323  0,119  Antibacterial
0,234  0,030  Lipid peroxidase inhibitor
0,223  0,019  GABA C receptor rho-2 antagonist
0,245  0,041  Antiviral (West Nile virus)
0,217  0,014  Alcohol dehydrogenase substrate
0,205  0,003  Ca2+-transporting ATPase inhibitor
0,223  0,023  ATPase inhibitor
0,215  0,015  Anticataract
0,263  0,064  Angiogenesis stimulant
0,206  0,007  GABA C receptor rho-1 antagonist
0,239  0,041  Nitric-oxide synthase stimulant
0,229  0,032  Muscular dystrophy treatment
0,210  0,014  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,291  0,096  Antiallergic
0,200  0,007  Phenylalanine 4-hydroxylase inhibitor
0,204  0,012  Adenylate cyclase stimulant
0,196  0,003  Aconitate hydratase inhibitor
0,200  0,008  Keratolytic
0,197  0,005  Acyl-CoA dehydrogenase inhibitor
0,243  0,051  UDP-glucuronosyltransferase substrate
0,241  0,050  UGT1A1 substrate
0,197  0,006  Interferon agonist
0,198  0,009  ABCA1 expression enhancer
0,203  0,015  Menstruation disorders treatment
0,208  0,021  Cyclin-dependent kinase 5 inhibitor
0,233  0,046  CYP2B6 inhibitor
0,216  0,030  Genotoxic
0,239  0,053  Antialcoholic
0,234  0,050  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,198  0,016  UGT2B1 substrate
0,186  0,006  Anabolic
0,197  0,017  Sulfotransferase substrate
0,216  0,037  UGT2B15 substrate
0,193  0,015  Sphingosine 1-phosphate receptor 5 antagonist
0,191  0,013  Pregnane X receptor agonist
0,298  0,120  Antineoplastic (breast cancer)
0,205  0,028  Cell wall synthesis inhibitor
0,206  0,030  Antiprotozoal (Coccidial)
0,187  0,011  Prolactin inhibitor
0,263  0,089  CYP1A2 substrate
0,195  0,021  Microtubule formation inhibitor
0,211  0,036  Aldehyde oxidase substrate
0,225  0,051  Insulin sensitizer
0,235  0,062  Peptidyltransferase inhibitor
0,258  0,088  Spasmolytic
0,174  0,005  Antiviral (Dengue virus)
0,183  0,013  Sphingosine 1-phosphate receptor 2 antagonist
0,190  0,021  Antischistosomal
0,197  0,029  Neurotrophic factor
0,203  0,035  Bone formation stimulant
0,174  0,008  UGT2B11 substrate
0,179  0,013  NADH dehydrogenase inhibitor
0,170  0,004  Antiviral (Parainfluenza)
0,170  0,005  Neuraminidase inhibitor
0,188  0,024  Antiviral (Poxvirus)
0,203  0,040  Protein kinase stimulant
0,188  0,026  Retinoprotector
0,187  0,025  Antineoplastic antimetabolite
0,183  0,021  Coagulant
0,166  0,005  Glycine receptor antagonist
0,186  0,025  Aminopeptidase B inhibitor
0,179  0,019  Contraceptive female
0,168  0,007  Lanosterol 14 alpha demethylase inhibitor
0,178  0,019  Vanilloid 1 agonist
0,263  0,105  Interleukin 2 agonist
0,163  0,005  Liver X receptor agonist
0,173  0,014  Actinic keratosis treatment
0,208  0,050  5 Hydroxytryptamine 3E antagonist
0,244  0,087  Antioxidant
0,166  0,010  Antiviral (SARS coronavirus)
0,166  0,010  Antiviral (Coronavirus)
0,174  0,019  Aldehyde dehydrogenase substrate
0,187  0,032  Cachexia treatment
0,169  0,013  Electron transport complex I inhibitor
0,180  0,025  Shock treatment
0,175  0,020  Antineoplastic, alkylator
0,163  0,011  Glutamate decarboxylase inhibitor
0,161  0,008  Biliverdin reductase inhibitor
0,166  0,014  Electrolyte absorption antagonist
0,172  0,021  Photosensitizer
0,195  0,045  Phospholipase A2 inhibitor
0,202  0,053  VEGF expression inhibitor
0,246  0,100  Insulysin inhibitor
0,166  0,022  Antihelmintic (Fasciola)
0,155  0,011  Interleukin 12 antagonist
0,227  0,084  Vasodilator
0,189  0,049  Antiviral (Hepatitis C)
0,144  0,005  Interferon inducer
0,143  0,004  Glutamate (mGluR6) antagonist
0,155  0,017  Antifungal (Pneumocystis)
0,176  0,039  Monophenol monooxygenase inhibitor
0,157  0,019  Carcinogenic, group 2A
0,140  0,003  Glucose-6-phosphate isomerase inhibitor
0,155  0,019  Histidine decarboxylase inhibitor
0,197  0,062  Antiviral (Hepatitis)
0,167  0,033  Antismoking
0,157  0,023  Antiinfertility, female
0,143  0,009  GABA aminotransferase inhibitor
0,189  0,056  Antihelmintic (Nematodes)
0,176  0,043  Skin whitener
0,140  0,007  Anticholelithogenic
0,220  0,088  Neuropeptide Y2 antagonist
0,136  0,003  Neuraminidase (Influenza A) inhibitor
0,158  0,026  TRPA1 agonist
0,152  0,020  DOPA decarboxylase inhibitor
0,151  0,022  Interleukin-1 receptor-associated protein kinase 4 inhibitor
0,179  0,050  Hexokinase inhibitor
0,179  0,051  Neurotensin receptor agonist
0,140  0,014  Aminopeptidase I inhibitor
0,154  0,030  Sphingosine 1-phosphate receptor 4 antagonist
0,161  0,036  Cystathionine beta-synthase inhibitor
0,154  0,030  Mucolytic
0,135  0,012  Dysmenorrhea treatment
0,181  0,057  Phobic disorders treatment
0,180  0,058  Prostate disorders treatment
0,161  0,039  Cyclooxygenase 3 inhibitor
0,273  0,151  CYP2C19 inhibitor
0,209  0,087  Cyclic AMP phosphodiesterase inhibitor
0,226  0,105  Huntington's disease treatment
0,147  0,026  Sphingomyelinase inhibitor
0,164  0,043  Toll-Like receptor 2 antagonist
0,135  0,015  Phosphodiesterase 6D inhibitor
0,129  0,010  Antiviral (Hepatitis A)
0,125  0,006  GABA B receptor agonist
0,159  0,042  Aldehyde dehydrogenase inhibitor
0,152  0,035  Falcipain 3 inhibitor
0,158  0,042  Proteasome inhibitor
0,121  0,005  Antidote, organophosphates
0,130  0,014  Leukotriene synthesis inhibitor
0,144  0,028  HIV-1 integrase (Overall Integration) inhibitor
0,127  0,012  Ornithine carbamoyltransferase inhibitor
0,155  0,040  Antiprotozoal (Amoeba)
0,134  0,021  Ankylosing spondylitis treatment
0,124  0,013  Granulocyte macrophage colony stimulating factor agonist
0,154  0,044  Antihelmintic (Trematoda)
0,153  0,044  Cathepsin H inhibitor
0,130  0,022  Tourette's syndrome treatment
0,186  0,078  Platelet adhesion inhibitor
0,175  0,069  Antipruritic
0,116  0,012  Estrogen-related receptor beta agonist
0,159  0,055  Hearing loss treatment
0,152  0,049  Antiprotozoal (Trichomonas)
0,130  0,027  Potassium channel activator
0,132  0,030  Folate antagonist
0,106  0,005  MDM2 inhibitor
0,124  0,023  Ornithine decarboxylase inhibitor
0,187  0,086  Antiviral (Ebola)
0,107  0,006  SULT2A1 substrate
0,113  0,013  Purinergic P2X1 antagonist
0,157  0,057  Movement disorders treatment
0,110  0,012  Androgen agonist
0,114  0,016  SULT1A2 substrate
0,161  0,063  Aldose reductase substrate
0,267  0,168  Analgesic
0,151  0,053  Nav1.6 sodium channel blocker
0,117  0,020  NAT1 substrate
0,113  0,016  Narcotic antagonist
0,103  0,006  Alpha-mannosidase inhibitor
0,102  0,005  Peroxisome proliferator-activated receptor delta antagonist
0,102  0,005  Liver X receptor beta agonist
0,101  0,005  Andropause treatment
0,108  0,013  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,135  0,041  Caspase 3 inhibitor
0,104  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,130  0,036  Gastric antisecretory
0,117  0,024  Glutamate release inhibitor
0,122  0,029  Paget's disease treatment
0,106  0,013  Vanilloid 4 agonist
0,148  0,056  Antieczematic
0,096  0,004  Membrane dipeptidase inhibitor
0,146  0,056  Farnesoid X receptor antagonist
0,156  0,067  Antidote
0,172  0,083  LDLR expression enhancer
0,111  0,023  Na+ K+ transporting ATPase inhibitor
0,131  0,043  NAT2 substrate
0,092  0,004  Cytokine production stimulant
0,099  0,011  Phosphodiesterase II inhibitor
0,151  0,064  Antineoplastic (squamous cell carcinoma)
0,117  0,030  Antiviral (Rhinovirus)
0,130  0,044  Expectorant
0,125  0,039  Antiprotozoal (Toxoplasma)
0,122  0,037  Factor V inhibitor
0,100  0,015  Potassium channel (ATP-sensitive) blocker
0,100  0,015  Peroxisome proliferator-activated receptor gamma antagonist
0,135  0,051  Antiviral (Papilloma)
0,147  0,063  Antifungal (Cryptococcus)
0,206  0,122  Amyotrophic lateral sclerosis treatment
0,102  0,017  Bulimia treatment
0,143  0,060  Aurora-C kinase inhibitor
0,088  0,008  Phosphoglycerate kinase inhibitor
0,086  0,006  Liver X receptor alpha agonist
0,152  0,072  Pulmonary hypertension treatment
0,087  0,007  Mannosidase inhibitor
0,143  0,064  Heat shock protein 70 antagonist
0,123  0,044  Carbonic anhydrase XV inhibitor
0,116  0,037  Alcohol dehydrogenase inhibitor
0,116  0,038  Calcium antagonist
0,089  0,011  Phosphodiesterase 2A inhibitor
0,088  0,011  Sphingosine kinase inhibitor
0,168  0,092  Systemic lupus erythematosus treatment
0,090  0,014  Exportin-1 inhibitor
0,134  0,059  DNA polymerase I inhibitor
0,142  0,067  Pancreatic disorders treatment
0,081  0,006  Pregnane X receptor antagonist
0,078  0,004  Kainate receptor agonist
0,149  0,076  Acute respiratory distress syndrome (ARDS) treatment
0,090  0,017  Antimycoplasmal
0,151  0,079  Neuropathy treatment
0,155  0,083  Growth hormone agonist
0,079  0,006  Dopamine D5 agonist
0,090  0,018  Gaucher disease treatment
0,127  0,055  Antiprotozoal (Babesia)
0,105  0,033  Antileprosy
0,136  0,065  NADPH oxidase inhibitor
0,189  0,118  Antipyretic
0,084  0,013  Sphingosine kinase 2 inhibitor
0,166  0,095  P-glycoprotein inhibitor
0,083  0,012  Calcium channel P-type blocker
0,182  0,112  Antiviral (HIV)
0,086  0,016  Peroxisome proliferator-activated receptor alpha agonist
0,089  0,018  Glutamate (mGluR7) antagonist
0,082  0,011  Lysine-specific demethylase 1A inhibitor
0,145  0,076  Antianorexic
0,096  0,027  CC chemokine 5 receptor agonist
0,091  0,022  MAP kinase kinase 7 inhibitor
0,075  0,006  Geranyltranstransferase inhibitor
0,083  0,015  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,164  0,096  Hepatoprotectant
0,091  0,023  NMDA receptor agonist
0,090  0,022  Phospholipase D inhibitor
0,079  0,012  Mineralocorticoid receptor antagonist
0,115  0,048  Carbonic anhydrase III inhibitor
0,077  0,010  Lysophosphatidic acid 3 receptor antagonist
0,077  0,011  Squalene epoxidase inhibitor
0,105  0,038  Restless leg syndrome treatment
0,175  0,109  Transplant rejection treatment
0,123  0,058  Interleukin 8 antagonist
0,071  0,007  Arginase inhibitor
0,070  0,006  Hypogonadism treatment
0,087  0,024  Endocannabinoid uptake inhibitor
0,088  0,024  S-adenosyl-L-methionine decarboxylase inhibitor
0,113  0,049  Chronic obstructive bronchitis treatment
0,089  0,027  Leukotriene antagonist
0,086  0,023  Carbonic anhydrase stimulant
0,066  0,006  p53 inhibitor
0,084  0,024  Protease 3C (Human rhinovirus) inhibitor
0,116  0,056  Rhinitis treatment
0,106  0,046  Potassium channel (Voltage-sensitive) activator
0,064  0,005  ATP citrate lysase inhibitor
0,084  0,025  Potassium channel (Tandem pore domain) blocker
0,072  0,013  Adenosine deaminase inhibitor
0,115  0,056  Acetylcholine release stimulant
0,070  0,011  Potassium channel (Inward rectifier) activator
0,097  0,039  Carbonic anhydrase XIII inhibitor
0,068  0,010  Squalene synthetase inhibitor
0,064  0,006  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,077  0,020  Transcription factor RelA inhibitor
0,070  0,012  Adenylate cyclase 1 inhibitor
0,066  0,008  GABA uptake inhibitor
0,083  0,026  NMDA receptor glycine site agonist
0,062  0,006  Sodium-dependent vitamin C transporter 2 inhibitor
0,067  0,011  Potassium channel (ATP-sensitive) activator
0,086  0,030  Antitreponemal
0,062  0,006  Glutamate (mGluR8) agonist
0,068  0,012  Glutamate (mGluR1a) antagonist
0,106  0,050  MAP kinase kinase 1 inhibitor
0,096  0,041  Glutathione S-transferase inhibitor
0,135  0,080  Mannose-6-phosphate isomerase inhibitor
0,087  0,032  Phosphodiesterase VI inhibitor
0,073  0,018  Postcoital contraceptive
0,093  0,039  D-Ala-D-Ala ligase inhibitor
0,079  0,026  Antidote, heavy metal
0,094  0,041  mTOR complex 2 inhibitor
0,072  0,020  Glucosylceramidase inhibitor
0,071  0,019  Leukotriene B4 antagonist
0,077  0,026  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,113  0,063  Mental retardation treatment
0,056  0,005  Cholesterol ester transfer protein antagonist
0,127  0,076  Cocaine dependence treatment
0,059  0,009  Sphingosine kinase 1 inhibitor
0,193  0,143  Transcription factor STAT3 inhibitor
0,058  0,009  Prostaglandin agonist
0,062  0,013  Retinoid X receptor agonist
0,084  0,034  Sphingosine 1-phosphate receptor 4 agonist
0,188  0,139  Antineoplastic (pancreatic cancer)
0,095  0,046  Arylamine N-Acetyltransferase substrate
0,060  0,011  Guanylate cyclase inhibitor
0,118  0,070  Alkylator
0,089  0,040  T cell inhibitor
0,103  0,054  Glutamate (mGluR7) agonist
0,067  0,019  Potassium channel (Inward rectifier) blocker
0,066  0,018  Antiviral (Herpesvirus 3, Human)
0,068  0,021  Ryanodine receptor antagonist
0,100  0,053  Antifungal (Candida)
0,066  0,019  Glutamate (mGluR group I) agonist
0,142  0,095  Prostatic (benign) hyperplasia treatment
0,054  0,007  Cholesterol absorption inhibitor
0,135  0,088  Thiol protease inhibitor
0,067  0,020  Nicotinic alpha3beta2 receptor antagonist
0,076  0,030  Uterine relaxant
0,051  0,005  Prostaglandin EP2 agonist
0,082  0,037  Prostaglandin-E synthase inhibitor
0,086  0,042  Antibiotic
0,065  0,020  Leukotriene C antagonist
0,052  0,008  Lysophosphatidic acid 2 receptor antagonist
0,046  0,003  Neuraminidase (Influenza B) inhibitor
0,046  0,003  Vitamin D receptor agonist
0,047  0,004  Toll-Like receptor 8 agonist
0,065  0,022  Dihydroorotate oxidase inhibitor
0,108  0,065  Protein kinase C gamma inhibitor
0,056  0,013  Glucocorticoid antagonist
0,089  0,046  Glutamate receptor agonist
0,050  0,007  HMG CoA reductase inhibitor
0,106  0,063  AMP-activated protein kinase stimulant
0,047  0,004  Prostaglandin F2 alpha agonist
0,061  0,020  HCV NS3/NS4A protease inhibitor
0,114  0,073  Adenylate cyclase inhibitor
0,045  0,004  Nicotinic acid receptor 2 antagonist
0,066  0,025  Lipocortins synthesis agonist
0,052  0,011  Retinoid X receptor antagonist
0,115  0,075  Growth stimulant
0,097  0,057  Bile acid receptor antagonist
0,073  0,033  Antihemophilic
0,061  0,022  Immunoglobulin Fc receptor antagonist
0,091  0,052  Tocolytic
0,102  0,063  Protease inhibitor
0,059  0,020  Aldosterone antagonist
0,042  0,003  Potassium channel (Inward rectifier) 11 blocker
0,044  0,005  Free fatty acid receptor 1 agonist
0,044  0,005  Glucocorticoid agonist
0,056  0,017  AICAR transformylase inhibitor
0,057  0,019  CC chemokine 4 receptor antagonist
0,050  0,013  Peroxisome proliferator-activated receptor delta agonist
0,113  0,075  Acetylcholine muscarinic antagonist
0,041  0,004  Vanilloid 2 agonist
0,042  0,005  Lysophosphatidic acid receptor 1 agonist
0,042  0,006  Purinergic P2Y15 antagonist
0,063  0,027  Cannabinoid CB2 receptor antagonist
0,045  0,010  Retinoid X alpha receptor antagonist
0,051  0,016  Angiotensin AT1 receptor antagonist
0,040  0,005  Hedgehog signaling activator
0,056  0,020  Glutamate (mGluR5) agonist
0,050  0,014  Retinoid X alpha receptor agonist
0,055  0,020  Leukocyte elastase inhibitor
0,081  0,047  Estrogen receptor alpha antagonist
0,175  0,141  Calpain inhibitor
0,111  0,077  Beta amyloid protein antagonist
0,042  0,008  Glutamate (mGluR3) agonist
0,039  0,005  Estrogen-related receptor gamma antagonist
0,044  0,011  Liver X receptor beta antagonist
0,101  0,068  HDL-cholesterol increasing
0,043  0,010  Uridine phosphorylase inhibitor
0,116  0,084  Gastritis treatment
0,130  0,098  Urolithiasis treatment
0,041  0,009  Peroxisome proliferator-activated receptor alpha antagonist
0,041  0,009  Calcium-independent phospholipase A2 inhibitor
0,053  0,022  Oxytocin agonist
0,054  0,023  Microtubule stabilization
0,126  0,095  Corneal wound healing stimulator
0,032  0,001  Vitamin D-like
0,077  0,046  Cathepsin G inhibitor
0,142  0,111  Tumour necrosis factor antagonist
0,049  0,019  Thymidine kinase inhibitor
0,034  0,004  Carbonic anhydrase X inhibitor
0,034  0,004  Carbonic anhydrase VIII inhibitor
0,046  0,017  Farnesoid X receptor agonist
0,045  0,016  Glutamate (mGluR3) antagonist
0,063  0,034  Sphingosine 1-phosphate receptor 3 antagonist
0,223  0,195  CYP2C9 inhibitor
0,042  0,013  Peptide deformylase inhibitor
0,068  0,040  CDK1/cyclin B inhibitor
0,116  0,088  Antibacterial (Helicobacter pylori)
0,041  0,013  GABA transporter 3 inhibitor
0,045  0,017  Potassium channel Kv1.1 blocker
0,049  0,022  CDK5/p25 inhibitor
0,046  0,019  AMPA 4 receptor antagonist
0,031  0,004  Lysophosphatidic acid receptor 3 agonist
0,035  0,008  Sodium/glucose cotransporter 1 inhibitor
0,086  0,060  Histamine N-methyltransferase inhibitor
0,030  0,003  Telomerase stimulant
0,096  0,069  Bronchodilator
0,043  0,016  Vanilloid 3 antagonist
0,107  0,081  Autism spectrum disorders treatment
0,046  0,020  G protein-coupled receptor agonist
0,105  0,079  Antitussive
0,041  0,015  Free fatty acid receptor 1 antagonist
0,033  0,007  GRP78 expression inhibitor
0,034  0,009  Sodium/glucose cotransporter inhibitor
0,049  0,024  Toll-Like receptor 2 agonist
0,039  0,013  Prostaglandin D2 agonist
0,054  0,029  CD45 antagonist
0,053  0,029  Topoisomerase II beta inhibitor
0,029  0,005  Retinoid X beta receptor antagonist
0,043  0,019  Leukotriene C4 antagonist
0,112  0,088  Allergic rhinitis treatment
0,084  0,060  Vanilloid agonist
0,031  0,009  Glutamate (mGluR1) agonist
0,054  0,031  Diacylglycerol O-acyltransferase inhibitor
0,032  0,010  Prostaglandin E2 agonist
0,042  0,019  Nicotinic acid receptor agonist
0,063  0,042  Adenosine A2a receptor antagonist
0,038  0,017  Angiotensin II receptor antagonist
0,046  0,026  Glutamate (mGluR group III) antagonist
0,025  0,005  Vesicular glutamate transport inhibitor
0,062  0,042  Beta 2 adrenoreceptor agonist
0,073  0,053  Adenosine A3 receptor antagonist
0,080  0,061  Sleep apnea treatment
0,047  0,028  Fructose-1,6-bisphosphatase inhibitor
0,027  0,008  Isoleucine-tRNA ligase inhibitor
0,114  0,095  Interleukin 4 antagonist
0,040  0,022  Kainate receptor 2 antagonist
0,129  0,110  MAP kinase 3 inhibitor
0,064  0,046  Beta 3 adrenoreceptor antagonist
0,049  0,031  Cholesterol esterase inhibitor
0,030  0,012  CC chemokine 1 receptor antagonist
0,143  0,127  I kappa B kinase epsilon inhibitor
0,023  0,007  Nicotinic acid receptor 1 antagonist
0,045  0,030  Dihydroorotase inhibitor
0,022  0,006  Methylmalonyl-CoA mutase inhibitor
0,032  0,016  Hypoxanthine phosphoribosyltransferase inhibitor
0,039  0,024  Potassium channel KCNQ activator
0,039  0,024  Delayed rectifier potassium channel activator
0,138  0,123  3C-like protease (Human coronavirus) inhibitor
0,033  0,018  Epoxide hydrolase 1 inhibitor
0,029  0,014  Sodium/glucose cotransporter 2 inhibitor
0,026  0,011  Glutamate (mGluR1a) agonist
0,040  0,025  Alpha 1d adrenoreceptor agonist
0,038  0,024  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,048  0,034  Dopamine beta hydroxylase inhibitor
0,038  0,024  Delayed rectifier potassium channel blocker
0,058  0,044  Heat shock protein 90 beta antagonist
0,052  0,038  Toll-Like receptor 8 antagonist
0,022  0,008  Antibiotic Anthracycline-like
0,121  0,107  Acetylcholine M1 receptor antagonist
0,043  0,029  GABA B receptor antagonist
0,047  0,033  Potassium channel Kv1.3 blocker
0,028  0,015  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,019  0,006  Thromboxane A2 agonist
0,043  0,030  Nerve growth factor antagonist
0,034  0,021  Carboxypeptidase B inhibitor
0,026  0,013  5 Hydroxytryptamine 4 agonist
0,021  0,008  Ileal bile acid transport inhibitor
0,029  0,017  Lysine carboxypeptidase inhibitor
0,057  0,045  Cathepsin E inhibitor
0,073  0,061  Sphingosine 1-phosphate receptor antagonist
0,102  0,090  Myasthenia Gravis treatment
0,036  0,024  Ceramide glucosyltransferase inhibitor
0,058  0,046  Potassium channel intermediate-conductance Ca-activated blocker
0,128  0,116  Protein kinase (CK1) gamma 3 inhibitor
0,022  0,010  Caspase 8 inhibitor
0,041  0,030  Sphingosine 1-phosphate receptor 1 agonist
0,058  0,047  Cannabinoid CB1 receptor antagonist
0,066  0,055  HIV-1 integrase inhibitor
0,022  0,012  Excitatory amino acid transporter 3 inhibitor
0,066  0,056  Secretase beta inhibitor
0,024  0,014  Fructose-1,6-bisphosphatase 1 inhibitor
0,028  0,018  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,043  0,033  Histamine H1 receptor agonist
0,015  0,006  Glutamate (mGluR6) agonist
0,032  0,023  Methionyl aminopeptidase 1 inhibitor
0,086  0,078  Xanthine oxidase inhibitor
0,015  0,007  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,023  0,015  ICAM 1 antagonist
0,053  0,045  Sphingosine 1-phosphate receptor 1 antagonist
0,036  0,028  Integrin alpha2 antagonist
0,139  0,131  MAP kinase kinase 2 inhibitor
0,030  0,022  Elastase 3B inhibitor
0,030  0,022  Elastase 2B inhibitor
0,030  0,022  Elastase 3A inhibitor
0,025  0,018  Methionyl aminopeptidase 2 inhibitor
0,073  0,066  Carbonic anhydrase VI inhibitor
0,162  0,155  DNA damaging
0,088  0,081  Urease inhibitor
0,027  0,020  LFA antagonist
0,040  0,034  Histamine H2 receptor agonist
0,016  0,010  Purinergic P2Y1 agonist
0,071  0,064  Antineoplastic antibiotic
0,032  0,025  Calcitonin receptor agonist
0,019  0,013  Estrogen-related receptor gamma agonist
0,016  0,010  Prostaglandin EP4 agonist
0,041  0,035  Glutamate (mGluR4) antagonist
0,047  0,041  Beta 2 adrenoreceptor antagonist
0,051  0,045  Thromboxane synthase inhibitor
0,159  0,154  Antineoplastic (liver cancer)
0,025  0,021  Integrin alpha2beta1 antagonist
0,025  0,020  Thymidine phosphorylase inhibitor
0,047  0,043  Ribonucleoside-diphosphate reductase inhibitor
0,063  0,058  Cannabinoid receptor antagonist
0,032  0,028  Glucose-dependent insulinotropic receptor agonist
0,031  0,028  Progesterone antagonist
0,012  0,009  Calcium-dependent phospholipase A2 inhibitor
0,047  0,044  Ribonucleotide reductase inhibitor
0,020  0,017  GABA transporter inhibitor
0,013  0,010  Angiotensin AT1B receptor antagonist
0,042  0,039  Antimetabolite
0,051  0,048  Epithelial sodium channel blocker
0,071  0,068  Chymotrypsin inhibitor
0,019  0,016  Antibiotic Quinolone-like
0,012  0,010  Carbonic anhydrase XI inhibitor
0,010  0,008  Thromboxane agonist
0,016  0,014  Aminopeptidase A inhibitor
0,031  0,029  Melatonin receptor 1A agonist
0,020  0,017  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,012  0,010  Antineoplastic (insulinoma)
0,017  0,015  CXC chemokine 5 receptor antagonist
0,024  0,022  Acid ceramidase inhibitor
0,009  0,007  Folate transporter 1 inhibitor
0,025  0,024  Retinoid X gamma receptor antagonist
0,040  0,038  Endothelin-converting enzyme inhibitor
0,019  0,018  Lysophosphatidic acid 1 receptor antagonist
0,049  0,048  Beta 1 adrenoreceptor antagonist
0,094  0,094  Antihypermotility
0,024  0,024  Calcium-sensing receptor agonist
0,050  0,049  Adenosine A1 receptor antagonist

